31 Mar 2023
Assets36.63
Total Income44.26
EBITDA20.07
Profit After Tax13.53
NET Worth22.73
Reserves and Surplus21.74
Total Borrowing9.78
At a glance
Updated 2026-08-24The shares listed at ₹83.00, a 5.06% move from the issue price. Gaudium IVF is a Mainboard IPO with an issue size of ₹165.00 crore, proposed for listing on BSE, NSE. The offer opens on 20th Feb 2026 and closes on 24th Feb 2026. The issue structure includes a fresh issue of ₹90.00 crore and an offer-for-sale component of ₹75.00 crore. The current listing schedule points to 27th Feb 2026.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹165.00 Cr
Fresh issue₹90.00 Cr
Offer for sale₹75.00 Cr
Face value₹5
Price band₹75.00–₹79.00
Allotment25th Feb 2026
Listing27th Feb 2026
Listing performance
Full performance ↗Issue price₹79.00
Listing price₹83.00
Current price—
Listing gain5.06%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹0.00
GMP / upper price0.00%
Est. listing₹79.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens20th Feb 2026
Closes24th Feb 2026
Allotment25th Feb 2026
Refund25th Feb 2026
Demat26th Feb 2026
Listing27th Feb 2026
Subscription demand
Full bidding ↗Total7.27×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 189 | ₹14,931 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure towards establishment of New IVF Centers of the Company. | ₹50.00 Cr |
| Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. | ₹20.00 Cr |
| General Corporate Purposes | ₹12.28 Cr |
| Issue Expenses | ₹14.15 Cr |
| Total | ₹96.43 Cr |
Financials
Full financials ↗31 Mar 2024
Assets51.01
Total Income48.15
EBITDA19.27
Profit After Tax10.32
NET Worth26.99
Reserves and Surplus26.00
Total Borrowing15.73
31 Mar 2025
Assets88.51
Total Income70.96
EBITDA28.63
Profit After Tax19.13
NET Worth46.30
Reserves and Surplus15.60
Total Borrowing18.93
30 Sep 2025
Assets106.62
Total Income49.75
EBITDA18.95
Profit After Tax12.51
NET Worth58.85
Reserves and Surplus28.16
Total Borrowing22.51
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 | Sep 30, 2025 |
|---|---|---|
| ROE | 41.31% | 21.25% |
| ROCE | 39.70% | 21.03% |
| Debt / Equity | 0.41% | 0.38% |
| RoNW | 41.71% | 21.34% |
| PAT Margin | 26.96% | 25.14% |
| EBITDA Margin | 40.48% | 38.29% |
| Price to Book Value | 10.48 |
Valuation & shareholding
Pre-IPO EPS3.12
Post-IPO EPS3.44
Pre-IPO P/E25.36
Post-IPO P/E22.99
Promoter holding pre99.99%
Promoter holding post71.30%
Market cap₹575.02 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure towards establishment of New IVF Centers of the Company. | ₹50.00 Cr |
| Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. | ₹20.00 Cr |
| General Corporate Purposes | ₹12.28 Cr |
| Issue Expenses | ₹14.15 Cr |
| Total | ₹96.43 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Sarthi Capital Advisors Pvt.Ltd.
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.